These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8639840)

  • 1. Comparison of activated protein C/protein S-mediated inactivation of human factor VIII and factor V.
    Lu D; Kalafatis M; Mann KG; Long GL
    Blood; 1996 Jun; 87(11):4708-17. PubMed ID: 8639840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of membrane-dependent factor Va cleavage: a mechanistic interpretation of the pathology of protein CVermont.
    Lu D; Kalafatis M; Mann KG; Long GL
    Blood; 1994 Aug; 84(3):687-90. PubMed ID: 8043858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor V is an anticoagulant cofactor for activated protein C during inactivation of factor Va.
    Cramer TJ; Griffin JH; Gale AJ
    Pathophysiol Haemost Thromb; 2010; 37(1):17-23. PubMed ID: 20501981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The C-terminal region of the factor V B-domain is crucial for the anticoagulant activity of factor V.
    Thorelli E; Kaufman RJ; Dahlbäck B
    J Biol Chem; 1998 Jun; 273(26):16140-5. PubMed ID: 9632668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of individual activated protein C cleavage site regions in coagulation factor V for factor Va inactivation and for factor Xa activation.
    Heeb MJ; Rehemtulla A; Moussalli M; Kojima Y; Kaufman RJ
    Eur J Biochem; 1999 Feb; 260(1):64-75. PubMed ID: 10091585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Arg306-->Ala and Arg506-->Gln substitutions in the inactivation of recombinant human factor Va by activated protein C and protein S.
    Egan JO; Kalafatis M; Mann KG
    Protein Sci; 1997 Sep; 6(9):2016-27. PubMed ID: 9300501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of inactivation of human factor V and human factor Va by activated protein C.
    Kalafatis M; Rand MD; Mann KG
    J Biol Chem; 1994 Dec; 269(50):31869-80. PubMed ID: 7989361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cleavage of factor V at Arg 506 by activated protein C and the expression of anticoagulant activity of factor V.
    Thorelli E; Kaufman RJ; Dahlbäck B
    Blood; 1999 Apr; 93(8):2552-8. PubMed ID: 10194434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor Va is inactivated by activated protein C in the absence of cleavage sites at Arg-306, Arg-506, and Arg-679.
    van der Neut Kolfschoten M; Dirven RJ; Vos HL; Tans G; Rosing J; Bertina RM
    J Biol Chem; 2004 Feb; 279(8):6567-75. PubMed ID: 14660667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex.
    Gierula M; Salles-Crawley II; Santamaria S; Teraz-Orosz A; Crawley JTB; Lane DA; Ahnström J
    J Thromb Haemost; 2019 Dec; 17(12):2056-2068. PubMed ID: 31364267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbohydrate moieties on the procofactor factor V, but not the derived cofactor factor Va, regulate its inactivation by activated protein C.
    Silveira JR; Kalafatis M; Tracy PB
    Biochemistry; 2002 Feb; 41(5):1672-80. PubMed ID: 11814362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
    Evenäs P; García de Frutos P; Nicolaes GA; Dahlbäck B
    Thromb Haemost; 2000 Aug; 84(2):271-7. PubMed ID: 10959700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emicizumab-mediated haemostatic function in patients with haemophilia A is down-regulated by activated protein C through inactivation of activated factor V.
    Yada K; Nogami K; Shinozawa K; Kitazawa T; Hattori K; Amano K; Fukutake K; Shima M
    Br J Haematol; 2018 Oct; 183(2):257-266. PubMed ID: 30125997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of factor V by the anticoagulant protease activated protein C: Influence of the B-domain and TFPIα.
    Ayombil F; Petrillo T; Kim H; Camire RM
    J Biol Chem; 2022 Nov; 298(11):102558. PubMed ID: 36183835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombin amino terminal region helps protect coagulation factor Va from proteolytic inactivation by activated protein C.
    Yegneswaran S; Nguyen PM; Gale AJ; Griffin JH
    Thromb Haemost; 2009 Jan; 101(1):55-61. PubMed ID: 19132189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals.
    Camire RM; Kalafatis M; Cushman M; Tracy RP; Mann KG; Tracy PB
    J Biol Chem; 1995 Sep; 270(35):20794-800. PubMed ID: 7657663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of surface epitopes of human coagulation factor Va that are important for interaction with activated protein C and heparin.
    Segers K; Dahlbäck B; Rosing J; Nicolaes GA
    J Biol Chem; 2008 Aug; 283(33):22573-81. PubMed ID: 18519572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of protein S and phospholipid for activated protein C-mediated cleavages in factor Va.
    Norstrøm EA; Steen M; Tran S; Dahlbäck B
    J Biol Chem; 2003 Jul; 278(27):24904-11. PubMed ID: 12707283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of recombinant FV Hong Kong and FV Cambridge.
    Norstrøm E; Thorelli E; Dahlbäck B
    Blood; 2002 Jul; 100(2):524-30. PubMed ID: 12091344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of P1 residues Arg336 and Arg562 in the activated-Protein-C-catalysed inactivation of Factor VIIIa.
    Varfaj F; Neuberg J; Jenkins PV; Wakabayashi H; Fay PJ
    Biochem J; 2006 Jun; 396(2):355-62. PubMed ID: 16503879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.